• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Corimmun

edit

Corimmun is a clinical drug developing company located in Martinsried near Munich, Germany, and is focused on novel therapeutics and diagnostics for heart and vascular diseases. Corimmun’s activities and experiences comprise all steps from research to drug development and commercialization.

Recent Milestones

edit

• 
  Corimmun received $880k (€680k) in Seed funding. (1/22/07)
  Posted 4/30/10 at 11:55pm via foerderland.de

Videos

Screenshots

edit

Above: Corimmun
Uploaded: 5/1/10

Sources

1. CORIMMUN GmbH announced today that it has completed a seed funding round with the High-Tech Gründerfonds, Bayern Kapital (Seedfonds) and BioM AG. (foerderland.de) [edit]